Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed

PLoS ONE

Volumn 4, Issue 5, 2009, Pages

  Tamburini, Beth A ^a   Trapp, Susan ^a,e   Phang, Tzu Lip ^a,b   Schappa, Jill T ^c   Hunter, Lawrence E ^a,b   Modiano, Jaime F ^a,b,c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e ARRAY BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; TRANSCRIPTION FACTOR; VASCULOTROPIN RECEPTOR 1; PROTEIN KINASE INHIBITOR;

ANGIOSARCOMA; ANIMAL DISEASE; ANIMAL EXPERIMENT; ARTICLE; BREED; CANCER CELL; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DOG; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GOLDEN RETRIEVER DOG; HERITABILITY; MALE; NONHUMAN; PHENOTYPE; ANIMAL; BREEDING; DOG DISEASE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; INHERITANCE; METABOLISM; TUMOR CELL LINE;

CANIS FAMILIARIS;

ANIMALS; BREEDING; CELL LINE, TUMOR; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HEMANGIOSARCOMA; INHERITANCE PATTERNS; MALE; PROTEIN KINASE INHIBITORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 66249123302     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005549     Document Type: Article

References (53)

1. Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, et al. (2006) Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol 101: 209-213.
2. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, et al. (2007) Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 39: 226-231.
3. Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, et al. (2008) Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res 68: 927-936.
4. Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, et al. (2006) The dog as a cancer model. Nat Biotechnol 24: 1065-1066.
5. Sutter NB, Eberle MA, Parker HG, Pullar BJ, Kirkness EF, et al. (2004) Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 14: 2388-2396.
6. Ostrander EA, Galibert F, Patterson DF (2000) Canine genetics comes of age. Trends Genet 16: 117-124.
7. Peterson MR, Frommelt RA, Dunn DG (2000) A study of the lifetime occurrence of neoplasia and breed differences in a cohort of German Shepherd Dogs and Belgian Malinois military working dogs that died in 1992. J Vet Intern Med 14: 140-145.
8. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
9. Vail DM, MacEwen EG (2000) Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18: 781-792.
10. Appleby EC, Hayward AH, Douce G (1978) German shepherds and splenic tumors. Vet Rec 102: 449.
11. Brown NO, Patnaik AK, MacEwen EG (1985) Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186: 56-58.
12. Priester WA, McKay FW (1980) The occurrence of tumors in domestic animals. Natl Cancer Inst Monogr. pp 1-210.
13. Prymak C, McKee LJ, Goldschmidt MH, Glickman LT (1988) Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193: 706-712.
14. Spangler WL, Culbertson MR (1992) Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985-1989). J Am Vet Med Assoc 200: 829-834.
15. Glickman L, Glickman N, Thorpe R (2000) The Golden Retriever Club of America National Health Survey. Golden Retriever Club of America (available at http://www.grca.org/healthsurvey.pdf).
16. Glickman LT, Glickman N, Raghavan M (2003) The Irish Setter Club of America 2003 National Health Survey. Irish Setter Club of America, Inc. (available at http://www.irishsetterclub.org/PDF/ Health%20Survey%20Results.pdf).
17. Tschoep K, Kohlmann A, Schlemmer M, Haferlach T, Issels RD (2007) Gene expression profiling in sarcomas. Crit Rev Oncol Hematol 63: 111-124.
18. Thomson SA, Kennerly E, Olby N, Mickelson JR, Hoffmann DE, et al. (2005) Microarray analysis of differentially expressed genes of primary tumors in the canine central nervous system. Vet Pathol 42: 550-558.
19. Dickerson EB, Thomas R, Fosmire SP, Lamerato-Kozicki AR, Bianco SR, et al. (2005) Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Vet Pathol 42: 618-632.
20. Wagner JL, Burnett RC, Storb R (1999) Organization of the canine major histocompatibility complex: current perspectives. J Hered 90: 35-38.
21. Volpert OV, Alani RM (2003) Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. Cancer Cell 3: 199-200.
22. Hogan C, Varga-Weisz P (2007) The regulation of ATP-dependent nucleosome remodelling factors. Mutat Res 618: 41-51.
23. Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, et al. (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Invest 84: 562-572.
24. Lamerato-Kozicki AR, Helm KM, Jubala CM, Cutter GC, Modiano JF (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34: 870-878.
25. Modiano JF, Breen M, Burnett RC, Parker HG, Inusah S, et al. (2005) Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 65: 5654-5661.
26. Tate G, Suzuki T, Mitsuya T (2007) Mutation of the PTEN gene in a human hepatic angiosarcoma. Cancer Genet Cytogenet 178: 160-162.
27. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
28. U'Ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW (2007) Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21: 113-120.
29. Selzner M, Bielawska A, Morse MA, Rudiger HA, Sindram D, et al. (2001) Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61: 1233-1240.
30. Haviv F, Bradley MF, Kalvin DM, Schneider AJ, Davidson DJ, et al. (2005) Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities. J Med Chem 48: 2838-2846.
31. Rusk A, McKeegan E, Haviv F, Majest S, Henkin J, et al. (2006) Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers. Clin Cancer Res 12: 7444-7455.
32. Hankenson KD, Hormuzdi SG, Meganck JA, Bornstein P (2005) Mice with a disruption of the thrombospondin 3 gene differ in geometric and biomechanical properties of bone and have accelerated development of the femoral head. Mol Cell Biol 25: 5599-5606.
33. Chen H, Aeschlimann D, Nowlen J, Mosher DF (1996) Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3. FEBS Lett 387: 36-41.
34. Clifford CA, Hughes D, Beal MW, Mackin AJ, Henry CJ, et al. (2001) Plasma vascular endothelial growth factor concentrations in healthy dogs and dogs with hemangiosarcoma. J Vet Intern Med 15: 131-135.
35. Shibuya M (2003) Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E. Cancer Sci 94: 751-756.
36. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
37. Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39: 469-478.
38. Hiratsuka S, Kataoka Y, Nakao K, Nakamura K, Morikawa S, et al. (2005) Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Mol Cell Biol 25: 355-363.
39. Thamm DH, Dickerson EB, Akhtar N, Lewis R, Auerbach R, et al. (2006) Biological and molecular characterization of a canine hemangiosarcoma-derived cell line. Res Vet Sci 81: 76-86.
40. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, et al. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109: 1801-1809.
41. Burton-Wurster N, Mateescu RG, Todhunter RJ, Clements KM, Sun Q, et al. (2005) Genes in canine articular cartilage that respond to mechanical injury: gene expression studies with Affymetrix canine GeneChip. J Hered 96: 821-828.
42. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, et al. (2005) Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438: 803-819.
43. Reiner A, Yekutieli D, Benjamini Y (2003) Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375.
44. Ferreira JA, Zwinderman A (2006) Approximate sample size calculations with microarray data: an illustration. Stat Appl Genet Mol Biol 5: Article25.
45. Page GP, Edwards JW, Gadbury GL, Yelisetti P, Wang J, et al. (2006) The PowerAtlas: a power and sample size atlas for microarray experimental design and research. BMC Bioinformatics 7: 84.
46. Irizarry RA, Ooi SL, Wu Z, Boeke JD (2003) Use of mixture models in a microarray-based screening procedure for detecting differentially represented yeast mutants. Stat Appl Genet Mol Biol 2: Article1.
47. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
48. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
49. Akhtar N, Padilla ML, Dickerson EB, Steinberg H, Breen M, et al. (2004) Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 6: 106-116.
50. Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Fosmire SP, et al. (2005) CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma. Vet Pathol 42: 468-476.
51. Modiano JF, Ritt MG, Wojcieszyn J, Smith R 3rd (1999) Growth arrest of melanoma cells is differentially regulated by contact inhibition and serum deprivation. DNA Cell Biol 18: 357-367.
52. Modiano JF, Domenico J, Szepesi A, Lucas JJ, Gelfand EW (1994) Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J Biol Chem 269: 32972-32978.
53. Modiano JF, Kolp R, Lamb RJ, Nowell PC (1991) Protein kinase C regulates both production and secretion of interleukin 2. J Biol Chem 266: 10552-10561.